As of 2025-09-13, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.51 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -100.8%.
The range of the Relative Valuation is (0.01) - (0.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | 0.1x - 0.3x | 0.1x |
| Fair Price | (0.01) - (0.04) | (0.01) |
| Upside | -100.7% - -102.5% | -100.8% |
| Date | P/E |
| 2025-09-10 | -12.02 |
| 2025-09-09 | -11.86 |
| 2025-09-08 | -11.62 |
| 2025-09-05 | -11.62 |
| 2025-09-04 | -11.22 |
| 2025-09-03 | -10.90 |
| 2025-09-02 | -10.74 |
| 2025-08-29 | -10.90 |
| 2025-08-28 | -10.42 |
| 2025-08-27 | -10.58 |
| 2025-08-26 | -10.58 |
| 2025-08-25 | -11.78 |
| 2025-08-22 | -10.82 |
| 2025-08-21 | -10.82 |
| 2025-08-20 | -10.82 |
| 2025-08-19 | -11.06 |
| 2025-08-18 | -10.98 |
| 2025-08-15 | -10.34 |
| 2025-08-14 | -9.77 |
| 2025-08-13 | -8.97 |
| 2025-08-12 | -7.85 |
| 2025-08-11 | -8.65 |
| 2025-08-08 | -8.09 |
| 2025-08-07 | -8.25 |
| 2025-08-05 | -8.65 |
| 2025-08-01 | -8.65 |
| 2025-07-31 | -8.57 |
| 2025-07-30 | -8.49 |
| 2025-07-29 | -8.49 |
| 2025-07-28 | -8.49 |
| 2025-07-25 | -8.49 |
| 2025-07-24 | -8.41 |
| 2025-07-23 | -8.33 |
| 2025-07-22 | -8.25 |
| 2025-07-21 | -8.17 |
| 2025-07-18 | -8.09 |
| 2025-07-17 | -8.01 |
| 2025-07-16 | -7.85 |
| 2025-07-15 | -7.77 |
| 2025-07-11 | -7.77 |
| 2025-07-04 | -7.77 |
| 2025-07-03 | -7.77 |
| 2025-07-02 | -7.77 |
| 2025-06-30 | -7.45 |
| 2025-06-27 | -7.61 |
| 2025-06-25 | -7.45 |
| 2025-06-24 | -7.45 |
| 2025-06-23 | -7.45 |
| 2025-06-20 | -7.21 |
| 2025-06-19 | -7.21 |